Main glossary
Special | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
I |
---|
IsomerMolecules with identical formulas but distinct
structures | |
L |
---|
Lay (person)The term 'lay' means non-professional. In research, it refers to the people who are neither academic researchers nor health or social care professionals. | |
Licence | |
LicensedWhen a product has been given a marketing
authorisation (product licence) by a medicines regulator, meaning it can be
placed on the market | |
Literature reviewA comprehensive summary of previous research on a topic. | |
M |
---|
Market ExclusivityA fixed period of time during which similar
medicines for the same indication as the drug granted market exclusivity,
cannot be placed on the market. The EMA grant market exclusivity for a 10-year
period after the marketing authorisation of an orphan drug | |
Marketing authorisationThe approval to market a medicine in one,
several or all of the European Union Member States | |
Markov modelsA type of model that assumes that patients move between different health states through the course of their disease. These health states are associated with particular costs and quality of life levels, and the time spent in these health states determines the overall costs and benefits experienced by the patients. | |
MetaboliteAn intermediate or end product of metabolism | |
MiningLiterature mining is the process of extracting facts/data
from text in the scientific literature. Literature mining can generate new
hypotheses by scrutinising large numbers of publications | |
Social networks